Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ENDOKRINOLOGI OG INDREMEDISIN AS
AS
Active
Org 933486702
Huvikveien 21D, 3222
Sandefjord
General medical practice activities
· NACE 8621
Est. 2024
— employees
Watchlist
Share
Norway
/
Companies
/
General medical practice activities
/
ENDOKRINOLOGI OG INDREMEDISIN AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
1M
2M
2M
2M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
-1M
2024
Income statement
NOK thousands
Item
2024
Revenue
1 679
Staff expenses
−1 441
EBITDA
−607
Depreciation & amort.
−120
EBIT
−727
Net financials
−18
Profit before tax
−746
Tax
−0
Net profit
−746
Balance sheet
NOK thousands
Item
2024
Total assets
3 898
Equity
−721
Long-term debt
3 379
Short-term debt
1 240
Total debt
4 619
Financial ratios
5-year trend
EBITDA margin
-36.2%
This company
15.8%
Market median
-329% vs market
2024
2024
Equity ratio
-18.5%
This company
38.2%
Market median
-148% vs market
2024
2024
Return on equity
-74551200.0%
This company
18.4%
Market median
-405169665% vs market
2024
2024
Net profit margin
-44.4%
This company
8.1%
Market median
-648% vs market
2024
2024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
2024
2024
Debt / equity
6.40×
This company
0.62×
Market median
-932% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
More on ENDOKRINOLOGI OG INDREMEDISIN AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
